<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 24 Aug 2026 17:22:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          AbCellera Biologics Inc.  For: Aug 24  Filed by: Hayden Michael R</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+24++Filed+by%3A+Hayden+Michael+R/26969183.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26969183.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+24++Filed+by%3A+Hayden+Michael+R/26969183.html</guid>
   <pubDate>Mon, 24 Aug 2026 17:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49308943</category>
   	  </item>
  <item>
   <title>Form  4          AbCellera Biologics Inc.  For: Aug 24  Filed by: Hayden Michael R</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+24++Filed+by%3A+Hayden+Michael+R/26969183.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26969183.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+24++Filed+by%3A+Hayden+Michael+R/26969183.html</guid>
   <pubDate>Mon, 24 Aug 2026 17:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49308943</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</link>
   <description>&lt;p&gt;&lt;strong&gt;News Provided by USA News Group on behalf of MindWalk Holdings Corp.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;NEW YORK, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;USA News Group&lt;/a&gt;&lt;strong&gt; News Commentary - &lt;/strong&gt;Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html</guid>
   <pubDate>Wed, 19 Aug 2026 08:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ABSI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HYFT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	  </item>
  <item>
   <title>Form  4          AbCellera Biologics Inc.  For: Aug 18  Filed by: Montalbano John S.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+18++Filed+by%3A+Montalbano+John+S./26943603.html</link>
   <description>si-local-file:///var/storage/secattach/20260818/26943603.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+18++Filed+by%3A+Montalbano+John+S./26943603.html</guid>
   <pubDate>Tue, 18 Aug 2026 14:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49308943</category>
   	  </item>
  <item>
   <title>Form  4          AbCellera Biologics Inc.  For: Aug 18  Filed by: Montalbano John S.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+18++Filed+by%3A+Montalbano+John+S./26943603.html</link>
   <description>si-local-file:///var/storage/secattach/20260818/26943603.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+18++Filed+by%3A+Montalbano+John+S./26943603.html</guid>
   <pubDate>Tue, 18 Aug 2026 14:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49308943</category>
   	  </item>
  <item>
   <title>Form  4          AbCellera Biologics Inc.  For: Aug 14  Filed by: Booth Andrew</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+14++Filed+by%3A+Booth+Andrew/26927555.html</link>
   <description>si-local-file:///var/storage/secattach/20260814/26927555.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AbCellera+Biologics+Inc.++For%3A+Aug+14++Filed+by%3A+Booth+Andrew/26927555.html</guid>
   <pubDate>Fri, 14 Aug 2026 12:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ABCL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49308943</category>
   	  </item>
 </channel>
</rss>
